Concord Biotech Dividends and Buybacks
Dividend criteria checks 3/6
Concord Biotech is a dividend paying company with a current yield of 0.44% that is well covered by earnings.
Key information
0.4%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 0.8% |
| Dividend Growth | 200.2% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₹8.750 |
| Payout ratio | 30% |
Recent dividend and buyback updates
Recent updates
Concord Biotech Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Nov 14
Do Concord Biotech's (NSE:CONCORDBIO) Earnings Warrant Your Attention?
Sep 15Concord Biotech Limited (NSE:CONCORDBIO) Not Lagging Market On Growth Or Pricing
Jul 23Is Concord Biotech (NSE:CONCORDBIO) Using Too Much Debt?
Feb 14Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Too early to tell whether CONCORDBIO's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if CONCORDBIO's dividend payments are increasing as they only just started paying a dividend.
Dividend Yield vs Market
| Concord Biotech Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (CONCORDBIO) | 0.4% |
| Market Bottom 25% (IN) | 0.3% |
| Market Top 25% (IN) | 1.1% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast (CONCORDBIO) (up to 3 years) | 0.8% |
Notable Dividend: CONCORDBIO's dividend (0.44%) is higher than the bottom 25% of dividend payers in the Indian market (0.25%).
High Dividend: CONCORDBIO's dividend (0.44%) is low compared to the top 25% of dividend payers in the Indian market (1.14%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (29.7%), CONCORDBIO's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (47.2%), CONCORDBIO's dividend payments are well covered by cash flows.